- Abnormally high level of CA-19-9 in a benign ovarian cyst
-
Pyeon SY, Park JY, Ki KD, Lee JM
- KMID: 2314073
- Obstet Gynecol Sci.
- 2015 Nov;58(6):530-532.
- doi: 10.5468/ogs.2015.58.6.530
CA-19-9 antigen is mainly elevated in cases of gastrointestinal tract malignancy, including of the pancreas, colorectum, and biliary tract. CA 19-9 antigen can also be elevated in ovarian mucinous neoplasms,... -
- CITED
-
- Close
- SHARE
-
- Close
- Significant elevation in serum CA 125 and CA 19-9 levels with torsion of the hydrosalpinx in a postmenopausal woman
-
Kim JH, Jung HJ, Song SH
- KMID: 2386283
- Obstet Gynecol Sci.
- 2017 Jul;60(4):387-390.
- doi: 10.5468/ogs.2017.60.4.387
Isolated torsion of the fallopian tube in postmenopausal women is rare. In this case report, we detail the case of a 53-year-old patient who presented with adenomyosis and a left... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Usefulness of Preoperative and Postoperative CA-19-9 Antigen in Pancreatic and Bile Duct Neoplasms
-
Lee HG, Moon HJ, Heo JS, Noh JH, Sohn TS, Choi SH, Joh JW, Kim YI
- KMID: 2004533
- J Korean Surg Soc.
- 2003 Aug;65(2):145-149.
PURPOSE: The CA-19-9 antigen is a commonly used tumor marker for pancreatic and bile duct neoplasms. It is well known that the CA-19-9 antigen is a good predictor of resectability,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Relevance of Tumor Marker CA 19-9
-
Lee YS
- KMID: 2391362
- Korean J Gastroenterol.
- 2017 Aug;70(2):61-63.
- doi: 10.4166/kjg.2017.70.2.61
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Asymptomatically Increased CA 19-9
-
Kim J
- KMID: 2448604
- Korean J Pancreas Biliary Tract.
- 2017 Jul;22(3):114-117.
- doi: 10.15279/kpba.2017.22.3.114
Health care screening is becoming more popular in Korea as more people are interested in well-being and health. However, there are controversies regarding usefulness of screening. Tumor markers are frequently... -
- CITED
-
- Close
- SHARE
-
- Close
- Delayed radiation-induced inflammation accompanying a marked carbohydrate antigen 19-9 elevation in a patient with resected pancreatic cancer
-
Mattes MD, Cardinal J, Jacobson G
- KMID: 2327389
- Radiat Oncol J.
- 2016 Jun;34(2):156-159.
- doi: 10.3857/roj.2016.01732
Although carbohydrate antigen (CA) 19-9 is a useful tumor marker for pancreatic cancer, it can also become elevated from a variety of benign and malignant conditions. Herein we describe an... -
- CITED
-
- Close
- SHARE
-
- Close
- Normalization of Elevated CA 19-9 Level after Treatment in a Patient with the Nodular Bronchiectatic Form of Mycobacterium abscessus Lung Disease
-
Chang B, Han SG, Kim W, Ko Y, Song J, Hong G, Eom JS, Lee JH, Jhun BW, Koh WJ
- KMID: 2320434
- Tuberc Respir Dis.
- 2013 Jul;75(1):25-27.
Carbohydrate antigen 19-9 (CA 19-9) is a widely-used tumor marker in patients with pancreatic cancer. However, some patients with respiratory disease also exhibit elevated serum CA 19-9 levels. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Carbohydrate Antigen 19-9 Test in Healthy People and Necessity of Medical Follow-up in Individuals with Elevated Carbohydrate Antigen 19-9 Level
-
Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS
- KMID: 2459569
- Korean J Fam Med.
- 2019 Sep;40(5):314-322.
- doi: 10.4082/kjfm.18.0057
BACKGROUND: Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker whose level is elevated in many types of cancers and other benign conditions. CA 19-9 levels are frequently found to... -
- CITED
-
- Close
- SHARE
-
- Close
- High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis
-
Shin JK, Kim HC, Lee WY, Yun SH, Cho YB, Huh JW, Park YA, Chun HK
- KMID: 2438686
- Ann Surg Treat Res.
- 2019 Mar;96(3):107-115.
- doi: 10.4174/astr.2019.96.3.107
PURPOSE: The purpose of this study is to evaluate the prognostic value of preoperative serum CA 19-9 levels in colorectal cancer patients. METHODS: Between 2008 and 2011, 4,794 consecutive patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
-
Kim NH, Lee MY, Park JH, Park DI, Sohn CI, Choi K, Jung YS
- KMID: 2418926
- Yonsei Med J.
- 2017 Sep;58(5):918-924.
- doi: 10.3349/ymj.2017.58.5.918
PURPOSE: Limited data are available regarding the association between circulating serum carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 (CA 19-9) concentrations and colorectal adenoma. We aimed to investigate whether elevated... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the UniCel(TM) DxI 800 Immunoassay Analyzer in Measuring Five Tumor Markers
-
Park Y, Park Y, Park J, Kim HS
- KMID: 1776991
- Yonsei Med J.
- 2012 May;53(3):557-564.
- doi: 10.3349/ymj.2012.53.3.557
PURPOSE: Tumor marker concentrations in a given specimen measured by different analyzers vary according to assay methods, epitopes for antibodies used, and reagent specificities. Although great effort in quality assessment... -
- CITED
-
- Close
- SHARE
-
- Close
- Intralobar Pulmonary Sequestration Showing Increased Serum CA19-9
-
Ahn YH, Song MJ, Park SH
- KMID: 2319852
- Tuberc Respir Dis.
- 2012 Jun;72(6):507-510.
Carbohydrate antigen 19-9 (CA19-9) is a specific tumor marker of the biliary, pancreatic and gastrointestinal tracts. CA19-9 is occasionally elevated in serum in patiens with benign pulmonary diseases such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease
-
Kim MS, Jeon TJ, Park JY, Choi J, Shin WC, Park SE, Seo JY, Kim YM
- KMID: 2391367
- Korean J Gastroenterol.
- 2017 Aug;70(2):96-102.
- doi: 10.4166/kjg.2017.70.2.96
BACKGROUND/AIMS: Elevated carbohydrate antigen (CA) 19-9 level may be unable to differentiate between benign and malignant pancreatobiliary disease with obstructive jaundice. The study aims to determine the clinical interpretation and... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic factors following surgical resection of distal bile duct cancer
-
Chung YJ, Choi DW, Choi SH, Heo JS, Kim DH
- KMID: 2324874
- J Korean Surg Soc.
- 2013 Nov;85(5):212-218.
PURPOSE: Prognostic factors for distal bile duct cancer are contentious. This study was conducted to analyze the prognostic factors of distal bile duct cancer after surgery with the aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
-
Lee JW, Kim YT, Lee SH, Son JH, Kang JW, Ryu JK, Jang DK, Paik WH, Lee BS
- KMID: 2404724
- Gut Liver.
- 2018 Jan;12(1):102-110.
- doi: 10.5009/gnl16588
BACKGROUND/AIMS: To determine the prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in gallbladder cancer (GBC) during palliative chemotherapy. METHODS: One hundred and twenty-three patients with pathologically confirmed... -
- CITED
-
- Close
- SHARE
-
- Close
- The Relationship between Lewis/Secretor Genotypes and Serum Carbohydrate Antigen 19-9 Levels in a Korean Population
-
Park HD, Park KU, Song J, Ki CS, Han KS, Kim JQ
- KMID: 1096819
- Korean J Lab Med.
- 2010 Feb;30(1):51-57.
- doi: 10.3343/kjlm.2010.30.1.51
BACKGROUND: The Lewis histo-blood group system consists of 2 major antigens-Lea and Leb-and a sialyl Lewis antigen-carbohydrate antigen (CA) 19-9. We investigated the distribution of Lewis genotypes and evaluated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
-
Kim J, Lee YS, Hwang IK, Kang BK, Cho JY, Yoon YS, Han HS, Hwang JH
- KMID: 2133302
- J Korean Med Sci.
- 2015 Mar;30(3):259-263.
- doi: 10.3346/jkms.2015.30.3.259
The role of carcinoembryonic antigen (CEA) in pancreatic cancer remains poorly understood. Therefore, this study aimed to determine whether CEA is complementary to carbohydrate antigen 19-9 (CA19-9) in prognosis prediction... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparative Study on Serum Immunoglobulin and Tumor Marker Levels in the Patients with Autoimmune Pancreatitis and Pancreatobiliary Malignancies
-
Yoon H, Kim MH, Won SH, Park DH, Lee SS, Seo DW, Lee SK
- KMID: 1718064
- Korean J Gastroenterol.
- 2013 Jun;61(6):327-332.
- doi: 10.4166/kjg.2013.61.6.327
BACKGROUND/AIMS: Autoimmune pancreatitis (AIP) often occurs with obstructive jaundice in old age in cases of weight loss, mimicking pancreatobiliary cancer. This study aimed to determine the sensitivity and specificity serum... -
- CITED
-
- Close
- SHARE
-
- Close
- Cystic Neoplasm of the Pancreas: Its Diagnosis and Treatment
-
Roh HR, Kim SW, Suh KS, Park YH, Kim YT, Yoon YB, Lee KU
- KMID: 1772573
- Korean J Gastroenterol.
- 1999 Dec;34(6):815-826.
BACKGROUND/AIMS: It is important to differentiate cystic neoplasm of the pancreas from pseudocyst and distinguish individual cystic neoplasm for optimal treatment. METHODS: Clinicopathologic characteristics of sixty-four patients with cystic neoplasms... -
- CITED
-
- Close
- SHARE
-
- Close
- CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
-
Lee DW, Im SA, Kim YJ, Yang Y, Rhee J, Na II, Lee KH, Kim TY, Han SW, Choi IS, Oh DY, Kim JH, Kim TY, Bang YJ
- KMID: 2388326
- Cancer Res Treat.
- 2017 Jul;49(3):807-815.
- doi: 10.4143/crt.2016.326
PURPOSE: While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated.... -
- CITED
-
- Close
- SHARE
-
- Close
